Clinical and Translational Medicine (Nov 2023)
RNA interference therapy for targeting ANGPTL3 and atherogenic lipoproteins: Findings and implications of a recent phase I study
Abstract
No abstracts available.
Clinical and Translational Medicine (Nov 2023)